265
Pathologic assessment of response to neoadjuvant chemotherapy in ovarian cancer: correlation with survival
Pathologic assessment of response to neoadjuvant chemotherapy in ovarian cancer: correlation with survival
Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)